Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections

10 Jul 2018

Abstract excerpt

Nontuberculous mycobacterial pulmonary infections are emerging as a global health problem and pose a threat to susceptible individuals with structural or functional lung conditions such as cystic fibrosis, chronic obstructive pulmonary disease and bronchiectasis. Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC) species account for 70 to 95% of the pulmonary nontuberculous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Mycology
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30042757
DOI: 10.3389/fmicb.2018.01547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial InfectionsPMID 30042757Read ↗

MmpL3 a potential new target for development of novel anti-tuberculosis drugsSemantic proximity Read ↗

Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat TuberculosisSemantic proximity Read ↗

Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus.Semantic proximity Read ↗

Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.Semantic proximity Read ↗

HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid TransporterSemantic proximity Read ↗

Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.Semantic proximity Read ↗

A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3Semantic proximity Read ↗

Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid TransportSemantic proximity Read ↗

Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus InfectionsSemantic proximity Read ↗

MMPL-Family Proteins in Bacteria, Protozoa, Fungi, Plants and Animals: A Bioinformatics and Structural InvestigationSemantic proximity Read ↗

MmpL Proteins in Physiology and Pathogenesis of M. tuberculosisSemantic proximity Read ↗

Indoleamides are active against drug-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.